Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Neoleukin Therapeutics Inc | NLTX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.49 | 3.49 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 3.05 - 4.70 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 3.49 | USD |
Información Financiera Neoleukin Therapeutics Inc NLTX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
40.7M | 11.66M | - | 0 | -36.32M | -3.11 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Neoleukin Therapeutics Inc NLTX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
22/4/2024 | 15:44 | Edgar (US Regulatory) | Form 8-K - Current report |
02/4/2024 | 14:43 | Edgar (US Regulatory) | Form 8-K - Current report |
18/3/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
18/3/2024 | 15:04 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
14/3/2024 | 19:54 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/3/2024 | 19:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/3/2024 | 19:51 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
07/3/2024 | 15:29 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
04/3/2024 | 17:20 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
04/3/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
21/2/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 15:16 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
Histórico de Datos NLTX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 3.29 | 3.69 | 3.18 | 3.44 | 22,986 | 0.20 | 6.08% |
1 Year | 4.25 | 4.70 | 3.05 | 3.70 | 149,512 | -0.76 | -17.88% |
3 Years | 62.75 | 67.00 | 1.875 | 12.50 | 236,549 | -59.26 | -94.44% |
5 Years | 19.90 | 90.65 | 1.875 | 33.53 | 271,777 | -16.41 | -82.46% |